Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes

This study is aimed at investigating the expression, clinical significance, and biological role of CPT1A in kidney renal clear cell carcinoma (KIRC). We used the TCGA database and clinical pathology of tissue specimens to study the expression of CPT1A in KIRC. The expression of CPT1A in the kidney c...

Full description

Saved in:
Bibliographic Details
Main Authors: Yingkun Xu, Guangzhen Wu, Xue Ma, Jianyi Li, Ningke Ruan, Zhiyu Zhang, Yalei Cao, Yougen Chen, Qi Zhang, Qinghua Xia
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:International Journal of Genomics
Online Access:http://dx.doi.org/10.1155/2020/9493256
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849411622258343936
author Yingkun Xu
Guangzhen Wu
Xue Ma
Jianyi Li
Ningke Ruan
Zhiyu Zhang
Yalei Cao
Yougen Chen
Qi Zhang
Qinghua Xia
author_facet Yingkun Xu
Guangzhen Wu
Xue Ma
Jianyi Li
Ningke Ruan
Zhiyu Zhang
Yalei Cao
Yougen Chen
Qi Zhang
Qinghua Xia
author_sort Yingkun Xu
collection DOAJ
description This study is aimed at investigating the expression, clinical significance, and biological role of CPT1A in kidney renal clear cell carcinoma (KIRC). We used the TCGA database and clinical pathology of tissue specimens to study the expression of CPT1A in KIRC. The expression of CPT1A in the kidney cancer tissue was significantly lower than that in the normal tissue. Survival curves demonstrated that the expression was correlated with prognosis in patients. We used the plasmid transfection method to explore the biological role of CPT1A in renal cancer cells and performed CCK-8, wound healing, and Transwell invasion experiments. The results demonstrated that CPT1A can inhibit the proliferation, migration, and invasion of renal cancer cells. Subsequently, we employed a bioinformatics analysis to further elucidate the role of CPT1A. The PPI network diagram was plotted, along with the coexpression diagram, between CPT1A and ten associated genes. The heat map was plotted, and the hazard ratio analysis of these eleven genes in KIRC was performed. Furthermore, the CPT1A, LPL, CPT2, and EHHADH genes were used to establish a reliable prognostic risk signature in KIRC. GSEA analysis demonstrated that CPT1A modulates tumor development via a variety of biological pathways in KIRC. We believe that CPT1A most likely suppresses tumor progression by employing tumor “slimming” in KIRC. Collectively, the results indicate the potential of CPT1A as a novel prognostic indicator and potential therapeutic target in KIRC.
format Article
id doaj-art-58ca55dd60a04dd4b03234dbec847c08
institution Kabale University
issn 2314-436X
2314-4378
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series International Journal of Genomics
spelling doaj-art-58ca55dd60a04dd4b03234dbec847c082025-08-20T03:34:43ZengWileyInternational Journal of Genomics2314-436X2314-43782020-01-01202010.1155/2020/94932569493256Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related GenesYingkun Xu0Guangzhen Wu1Xue Ma2Jianyi Li3Ningke Ruan4Zhiyu Zhang5Yalei Cao6Yougen Chen7Qi Zhang8Qinghua Xia9Department of Urology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, ChinaDepartment of Urology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, ChinaDepartment of Pediatrics, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, ChinaDepartment of Urology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, ChinaThe Nursing College of Zhengzhou University, Zhengzhou, Henan 450001, ChinaDepartment of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, ChinaDepartment of Urology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, ChinaDepartment of Urology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, ChinaDepartment of Urology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, ChinaDepartment of Urology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, ChinaThis study is aimed at investigating the expression, clinical significance, and biological role of CPT1A in kidney renal clear cell carcinoma (KIRC). We used the TCGA database and clinical pathology of tissue specimens to study the expression of CPT1A in KIRC. The expression of CPT1A in the kidney cancer tissue was significantly lower than that in the normal tissue. Survival curves demonstrated that the expression was correlated with prognosis in patients. We used the plasmid transfection method to explore the biological role of CPT1A in renal cancer cells and performed CCK-8, wound healing, and Transwell invasion experiments. The results demonstrated that CPT1A can inhibit the proliferation, migration, and invasion of renal cancer cells. Subsequently, we employed a bioinformatics analysis to further elucidate the role of CPT1A. The PPI network diagram was plotted, along with the coexpression diagram, between CPT1A and ten associated genes. The heat map was plotted, and the hazard ratio analysis of these eleven genes in KIRC was performed. Furthermore, the CPT1A, LPL, CPT2, and EHHADH genes were used to establish a reliable prognostic risk signature in KIRC. GSEA analysis demonstrated that CPT1A modulates tumor development via a variety of biological pathways in KIRC. We believe that CPT1A most likely suppresses tumor progression by employing tumor “slimming” in KIRC. Collectively, the results indicate the potential of CPT1A as a novel prognostic indicator and potential therapeutic target in KIRC.http://dx.doi.org/10.1155/2020/9493256
spellingShingle Yingkun Xu
Guangzhen Wu
Xue Ma
Jianyi Li
Ningke Ruan
Zhiyu Zhang
Yalei Cao
Yougen Chen
Qi Zhang
Qinghua Xia
Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes
International Journal of Genomics
title Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes
title_full Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes
title_fullStr Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes
title_full_unstemmed Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes
title_short Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes
title_sort identification of cpt1a as a prognostic biomarker and potential therapeutic target for kidney renal clear cell carcinoma and establishment of a risk signature of cpt1a related genes
url http://dx.doi.org/10.1155/2020/9493256
work_keys_str_mv AT yingkunxu identificationofcpt1aasaprognosticbiomarkerandpotentialtherapeutictargetforkidneyrenalclearcellcarcinomaandestablishmentofarisksignatureofcpt1arelatedgenes
AT guangzhenwu identificationofcpt1aasaprognosticbiomarkerandpotentialtherapeutictargetforkidneyrenalclearcellcarcinomaandestablishmentofarisksignatureofcpt1arelatedgenes
AT xuema identificationofcpt1aasaprognosticbiomarkerandpotentialtherapeutictargetforkidneyrenalclearcellcarcinomaandestablishmentofarisksignatureofcpt1arelatedgenes
AT jianyili identificationofcpt1aasaprognosticbiomarkerandpotentialtherapeutictargetforkidneyrenalclearcellcarcinomaandestablishmentofarisksignatureofcpt1arelatedgenes
AT ningkeruan identificationofcpt1aasaprognosticbiomarkerandpotentialtherapeutictargetforkidneyrenalclearcellcarcinomaandestablishmentofarisksignatureofcpt1arelatedgenes
AT zhiyuzhang identificationofcpt1aasaprognosticbiomarkerandpotentialtherapeutictargetforkidneyrenalclearcellcarcinomaandestablishmentofarisksignatureofcpt1arelatedgenes
AT yaleicao identificationofcpt1aasaprognosticbiomarkerandpotentialtherapeutictargetforkidneyrenalclearcellcarcinomaandestablishmentofarisksignatureofcpt1arelatedgenes
AT yougenchen identificationofcpt1aasaprognosticbiomarkerandpotentialtherapeutictargetforkidneyrenalclearcellcarcinomaandestablishmentofarisksignatureofcpt1arelatedgenes
AT qizhang identificationofcpt1aasaprognosticbiomarkerandpotentialtherapeutictargetforkidneyrenalclearcellcarcinomaandestablishmentofarisksignatureofcpt1arelatedgenes
AT qinghuaxia identificationofcpt1aasaprognosticbiomarkerandpotentialtherapeutictargetforkidneyrenalclearcellcarcinomaandestablishmentofarisksignatureofcpt1arelatedgenes